This analysis examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical exploration. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of clinical trials that make decentralization necessary.

The analysis examines three technology pillars: blockchain infrastructure for secure consent, data integrity, and smart-contract automation; digital twins for virtual patient modeling, synthetic control arms, and protocol simulation; and artificial intelligence (AI)/machine learning (ML) as the intelligence layer for recruitment, monitoring, and predictive analytics. It maps the technology maturity, key innovators, funding activity, and strategic partnerships defining the landscape, and evaluates the clinical trial value chain and economic impact, including faster enrollment, improved retention, greater diversity, and stronger returns on investment.

• Are your teams prepared to shift from site-centric to patient-centric models to gain a competitive advantage?
• Is your technology roadmap aligned with digital twins to enable virtual patient modeling, synthetic control arms, and protocol simulation?
• What best practices and strategies will help you navigate the future of decentralized and AI-enabled clinical trials to stay ahead?